APA (7th ed.) Citation

Filioglou, D., Santa-Cruz, N., Leite, G. S. F., Davini, D. W., Cracchiolo, M. J., Baker, F. L., . . . Katsanis, E. (2025). A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo. Cancers, 17(11), 1889. https://doi.org/10.3390/cancers17111889

Chicago Style (17th ed.) Citation

Filioglou, Dimitrios, et al. "A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo." Cancers 17, no. 11 (2025): 1889. https://doi.org/10.3390/cancers17111889.

MLA (9th ed.) Citation

Filioglou, Dimitrios, et al. "A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo." Cancers, vol. 17, no. 11, 2025, p. 1889, https://doi.org/10.3390/cancers17111889.